Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference24 articles.
1. Profitability and market value of orphan drug companies: a retrospective, propensity-matched case-control study;Hughes;PLoS One,2016
2. Adopting orphan drugs—two dozen years of treating rare diseases;Haffner;N Engl J Med,2006
3. Some numbers behind Canada’s decision to adopt an orphan drug policy: US orphan drug approvals in Canada, 1997–2012;Herder;Health Policy,2016
4. Reimbursement of drugs for rare diseases through the public healthcare system in Canada: Where are we now?;Menon;Healthc Policy,2015
5. Drugs for exceptionally rare diseases: Do they deserve special status for funding?;Hughes;QJM,2005
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献